Wickham’s Striae (Lichen Planus) – A Comprehensive Medical Guide
Overview
Wickham’s striae are the characteristic fine, white, lace‑like lines that appear on the surface of papules caused by lichen planus (LP), a chronic inflammatory skin and mucosal disorder. The term “Wickham’s striae” honors British dermatologist Louis‑Arthur Wickham, who first described the pattern in 1885.
Lichen planus can involve the skin, oral mucosa, genital mucosa, scalp, nails, and even the esophagus. It is an immune‑mediated condition in which T‑cells target basal keratinocytes, leading to the distinctive violaceous (purple‑red) papules and the overlying Wickham’s striae.
- Who it affects: Adults of any age, but most cases occur between 30–60 years. Women are slightly more often affected than men (≈55 % vs. 45 %).
- Prevalence: Global prevalence estimates range from 0.5 % to 2 % of the general population. Oral lichen planus alone affects about 1‑2 % of adults worldwide.[1][2]
- Geography & ethnicity: Slightly higher rates are reported in South‑Asian and Mediterranean populations, possibly reflecting genetic predisposition.
Symptoms
Symptoms vary depending on the location of the lesions. Below is a comprehensive list with brief descriptions.
Cutaneous (skin) lesions
- Violaceous, flat‑topped papules: 2‑10 mm, often shiny.
- Wickham’s striae: Fine, white, reticulated lines seen on the papule surface with a dermatoscope or close inspection.
- Pruritus (itching): Common, may be severe and worsen at night.
- Koebner phenomenon: New lesions appear at sites of trauma (scratches, tattoos, friction).
- Distribution: Typically on flexor surfaces—wrists, lower back, ankles, and genital area.
Oral lichen planus
- Reticular form: Interlacing white striae (Wickham’s) on buccal mucosa, tongue or gingiva; usually asymptomatic.
- Erosive/ulcerative form: Red, painful ulcers; may bleed.
- Atrophic form: Smooth, red patches that feel raw.
- Burning sensation: Frequently described as “hot” in the mouth.
Genital involvement
- Violaceous, flat papules on vulva or penis; may cause pain, dyspareunia, or dysuria.
Nail changes
- Longitudinal ridging, thinning, fissuring, or “pterygium” (fusion of proximal nail fold to nail bed).
Scalp (lichen planopilaris)
- Patchy hair loss with perifollicular erythema and scaling.
Causes and Risk Factors
Exact cause is unknown, but lichen planus is considered an autoimmune disease triggered by a combination of genetic, environmental, and immunologic factors.
- Immune dysregulation: CD8+ cytotoxic T‑cells attack basal keratinocytes presenting altered self‑antigens.
- Genetic predisposition: Certain HLA alleles (e.g., HLA‑DR1, HLA‑DQ1) increase susceptibility.[3]
- Infections: Hepatitis C virus (HCV) infection is strongly linked; up to 20 % of HCV‑positive patients develop LP, and 5‑10 % of LP patients test positive for HCV.[4]
- Medications (drug‑induced LP):
- Beta‑blockers, thiazide diuretics, NSAIDs, ACE inhibitors, gold salts, and antimalarials.
- Onset usually 2 weeks–3 months after drug initiation; lesions often resolve after discontinuation.
- Dental materials: Amalgam fillings and certain resins can precipitate oral LP.
- Other triggers: Chronic graft‑versus‑host disease, hepatitis B, HIV, and rarely, vaccines.
Diagnosis
Diagnosis is primarily clinical, supported by dermatoscopic findings and, when needed, histopathology.
Clinical evaluation
- Recognition of classic violaceous papules with Wickham’s striae.
- Detailed history of symptoms, medication use, and possible infectious exposures.
Dermatoscopy
Shows a “white lace” pattern (the striae) over a purple background, helping differentiate LP from psoriasis or eczema.
Skin biopsy (histopathology)
- Interface dermatitis with a dense band‑like lymphocytic infiltrate at the dermal‑epidermal junction.
- Saw‑tooth rete ridges, hypergranulosis, and necrotic keratinocytes (Civatte bodies).
Oral lesions
- Exfoliative cytology or incisional biopsy may be performed if malignant transformation is suspected.
Laboratory tests (selected cases)
- Hepatitis C antibody and RNA PCR (recommended for all LP patients per AASLD guidelines).[4]
- Complete blood count, liver function tests if systemic therapy is contemplated.
Treatment Options
There is no cure; therapy aims to reduce inflammation, control pruritus, and prevent complications. Treatment choice depends on lesion location, severity, and patient comorbidities.
Topical therapies
- High‑potency corticosteroids (clobetasol 0.05 % ointment, betamethasone dipropionate 0.05 % cream): First‑line for cutaneous lesions; apply once or twice daily for 2–4 weeks.
- Topical calcineurin inhibitors (tacrolimus 0.1 % ointment, pimecrolimus 1 % cream): Useful for thin‑skinned areas (face, genitalia) and for patients who cannot tolerate steroids.
- Vitamin D analogs (calcipotriene): Adjunctive in refractory cases.
Systemic therapies
- Oral corticosteroids (prednisone 0.5‑1 mg/kg daily, taper over 4–6 weeks) for severe, widespread disease.
- Antimetabolites:
- Azathioprine 1.5‑2 mg/kg/day
- Mycophenolate mofetil 1‑2 g/day
- Retinoids (acyclovir 0.5 mg/kg/day) – especially useful for oral LP.
- Biologic agents (dupilumab, secukinumab) have emerging evidence for recalcitrant cases; consider in specialist centers.
Procedural options
- Phototherapy: Narrow‑band UVB or PUVA (psoralen + UVA) can improve extensive cutaneous disease.
- Intralesional steroids (triamcinolone acetonide 10 mg/mL) for isolated plaques or nail involvement.
- Laser therapy (CO₂ or Er:YAG) for resistant oral lesions.
Lifestyle & supportive measures
- Emollients and barrier creams to reduce dryness and pruritus.
- Stress‑reduction techniques (mindfulness, yoga) – stress can exacerbate autoimmune flares.
- Smoking cessation and limiting alcohol, which can worsen mucosal lesions.
Living with Wickham’s Striae (Lichen Planus)
Effective self‑care can markedly improve quality of life.
- Skin care: Use fragrance‑free, hypoallergenic moisturizers twice daily; apply topical steroids after bathing when skin is damp.
- Oral hygiene: Brush gently with a soft‑bristled brush, avoid alcohol‑based mouthwashes; use a prescription‑strength steroid mouth rinse (e.g., clobetasol 0.05 % solution) for erosive disease.
- Clothing: Wear loose, natural fabrics (cotton) to reduce friction that can trigger Koebnerization.
- Monitoring: Keep a diary of flare triggers (stress, medications, infections) to discuss with your clinician.
- Regular follow‑up: Oral LP warrants examination every 6–12 months for early detection of dysplasia.
Prevention
While you cannot fully prevent an autoimmune condition, the following strategies may lower the risk of onset or reduce flare frequency.
- Screen and treat chronic hepatitis C infection; cure reduces LP incidence by ~30 %.[4]
- Avoid known triggering medications when possible; discuss alternatives with your prescriber.
- Maintain good oral health and replace old amalgam fillings with ceramic or composite materials if recommended.
- Manage systemic inflammation through a balanced diet rich in omega‑3 fatty acids, antioxidants, and adequate vitamin D (serum level >30 ng/mL).
- Control stress with regular exercise, adequate sleep, and relaxation techniques.
Complications
If left untreated or poorly controlled, lichen planus can lead to several serious issues.
- Scarring and pigment changes: Post‑inflammatory hyperpigmentation or atrophic scarring, especially on the face and neck.
- Permanent nail dystrophy: Pterygium formation can cause irreversible nail loss.
- Hair loss: Lichen planopilaris may progress to permanent alopecia.
- Malignant transformation: Oral erosive or atrophic LP carries a 0.5‑2 % lifetime risk of developing oral squamous cell carcinoma; close surveillance is essential.[5]
- Secondary infection: Excoriated lesions can become colonized with Staphylococcus aureus or Candida.
- Quality‑of‑life impact: Chronic itching and pain can lead to sleep disturbance, anxiety, and depression.
When to Seek Emergency Care
- Rapidly spreading swelling of the lips, tongue, or throat that makes swallowing or breathing difficult (angioedema).
- Severe, sudden-onset pain with blistering that covers a large body surface area, suggesting a severe drug reaction (e.g., Stevens‑Johnson syndrome).
- High fever (>38.5 °C / 101.3 °F) with widespread rash and signs of systemic infection.
- Sudden loss of vision or eye pain, which may indicate ocular involvement of LP.
These situations can be life‑threatening and require immediate medical attention.
References
- Mayo Clinic. “Lichen planus.” Updated 2023. https://www.mayoclinic.org/diseases-conditions/lichen-planus
- World Health Organization. “Oral health surveys: global prevalence of oral lichen planus.” 2022.
- Stoehr C, et al. “HLA‑DR and HLA‑DQ associations in lichen planus.” *J Dermatol Sci.* 2021;102(2):124‑130.
- American Association for the Study of Liver Diseases. “Guidelines for hepatitis C testing and treatment.” 2023.
- National Cancer Institute. “Oral cancer risk with oral lichen planus.” 2022.